Table 2.
Correlation between ROR2 expression and clinicopathologic characteristics
| ROR2 expression | P value | ||
|---|---|---|---|
| Negative (n = 96) | Positive (n = 147) | ||
| Sex | |||
| Male | 74 | 126 | 0.089 |
| Female | 22 | 21 | |
| Age (years) | |||
| ≤ 60 | 40 | 62 | 1.000 |
| > 60 | 56 | 85 | |
| HBV | |||
| Negative | 56 | 89 | 0.789 |
| Positive | 40 | 58 | |
| HCV | |||
| Negative | 52 | 91 | 0.234 |
| Positive | 44 | 56 | |
| AFP (ng/ml) | |||
| ≤ 10 | 39 | 88 | 0.006a |
| > 10 | 55 | 59 | |
| PIVKAII (mAU/ml) | |||
| ≤ 40 | 41 | 60 | 0.893 |
| > 40 | 53 | 83 | |
| Differentiation | |||
| Well-moderate | 69 | 125 | 0.015a |
| Poor | 27 | 22 | |
| Tumor number | |||
| One | 75 | 112 | 0.756 |
| Multiple | 21 | 35 | |
| Tumor size (cm) | |||
| ≤ 5 | 64 | 101 | 0.779 |
| > 5 | 32 | 46 | |
| Vascular invasion | |||
| Negative | 80 | 124 | 0.859 |
| Positive | 16 | 23 | |
| Non-cancerous liver | |||
| No cirrhosis | 62 | 95 | 1.000 |
| Cirrhosis | 34 | 52 | |
| Wnt5a | |||
| Negative | 79 | 101 | 0.024a |
| Positive | 17 | 46 | |
HBV hepatitis B virus, HCV hepatitis C virus, AFP α-fetoprotein, PIVKAII protein induced by vitamin K absence or antagonist II
aP < 0.05